Fluoroestradiol F 18 has 3 known drug interactions based on U.S. FDA drug labeling data. 3 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Elacestrant, Fulvestrant, Tamoxifen. Patients taking Fluoroestradiol F 18 should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 3
- Major
- 3
Major (3)
- Fluoroestradiol F 18 + Elacestrant— Binds to estrogen receptor and competes with fluoroestradiol F 18, reducing detection of ER-positive lesions. Discontinu…
- Fluoroestradiol F 18 + Fulvestrant— Binds to estrogen receptor and competes with fluoroestradiol F 18, reducing detection of ER-positive lesions. Discontinu…
- Fluoroestradiol F 18 + Tamoxifen— Binds to estrogen receptor and competes with fluoroestradiol F 18, reducing detection of ER-positive lesions. Discontinu…